OPENLANE (NYSE:KAR – Get Free Report)‘s stock had its “outperform” rating reiterated by Barrington Research in a research report issued to clients and investors on Monday, Benzinga reports. They currently have a $25.00 price objective on the specialty retailer’s stock. Barrington Research’s price target would suggest a potential upside of 54.13% from the stock’s previous close.
OPENLANE Trading Up 2.0 %
Shares of KAR traded up $0.32 during trading hours on Monday, hitting $16.22. The company had a trading volume of 100,515 shares, compared to its average volume of 693,615. The company has a market capitalization of $1.76 billion, a PE ratio of 107.60, a price-to-earnings-growth ratio of 1.66 and a beta of 1.44. OPENLANE has a one year low of $12.86 and a one year high of $18.73. The company’s fifty day moving average price is $16.43 and its two-hundred day moving average price is $16.94.
OPENLANE (NYSE:KAR – Get Free Report) last announced its earnings results on Wednesday, August 7th. The specialty retailer reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.21 by ($0.02). OPENLANE had a net margin of 3.39% and a return on equity of 7.85%. The business had revenue of $431.80 million for the quarter, compared to analyst estimates of $426.11 million. During the same period in the prior year, the company earned $0.25 earnings per share. The company’s quarterly revenue was up 3.6% on a year-over-year basis. Analysts forecast that OPENLANE will post 0.77 earnings per share for the current year.
Institutional Inflows and Outflows
OPENLANE Company Profile
OPENLANE, Inc, together with its subsidiaries, operates as a digital marketplace for used vehicles, which connects sellers and buyers in North America, Europe, the Philippines, and Uruguay. The company operates through two segments, Marketplace and Finance. The Marketplace segment offers digital marketplace services for buying and selling used vehicles.
Read More
- Five stocks we like better than OPENLANE
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Intel: Is Now the Time to Be Brave?Â
- Best Aerospace Stocks Investing
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- What is a buyback in stocks? A comprehensive guide for investors
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for OPENLANE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OPENLANE and related companies with MarketBeat.com's FREE daily email newsletter.